Pocket Emergency Medicine (Pocket Notebook Series) 3rd Ed.

AV NODE BLOCK

Definition

• These occur when conduction from the atria to the AV node & into the His bundle is disrupted

• These blocks can anatomically be located above, w/i, or below the His bundle

• Classified as 1st-degree, 2nd-degree Mobitz I (Wenckeback), 2nd-degree Mobitz II, & 3rd-degree blocks based on characteristic ECG patterns:

Approach

• Differentiate 1st, 2nd Mobitz I (Wenckebach), 2nd Mobitz II, & 3rd-degree blocks

• 2° Mobitz II & 3° blocks are never nl → look for underlying cardiac dz

• In children, be highly suspicious of toxic ingestion

• In neonates, consider congenital cardiac dz

• Determine (1) rate, (2) wide or narrow QRS, (3) rhythm regular or irregular, (4) P waves present or absent, (5) every P wave followed by QRS & every QRS preceded by P

History

• 1°: Asymptomatic, incidental finding on ECG

• 2° Mobitz I (Wenckebach): Often asymptomatic; irregular heartbeat, fatigue

• 2° Mobitz II: May be asymptomatic; presyncope/syncope, fatigue, DOE

• 3° usually symptomatic; presyncope/syncope, fatigue, weakness, DOE

Findings

• See above

Evaluation

• ECG & rhythm strip

• 2° Mobitz II & 3°: Labs in anticipation of PPM placement

Treatment

• 1° & 2° Mobitz I: No tx generally necessary

• 2° Mobitz II & 3°:

• Continuous tele monitoring

• Symptomatic pts require transcutaneous &/or transvenous pacing; if HD unstable, consider a beta-adrenergic agent (dopamine, epinephrine, or isoproterenol) as bridge to pacing. Dopamine has been demonstrated to have equivalent survival outcomes & adverse events to transcutaneous pacing (PrePACE, Resuscitation 2008;76(3):341)

• Treat active cardiac ischemia

• Consult cardiology

Disposition

• Pts w/ 1° & 2° Mobitz I: D/c home w/ f/u

• Pts w/ 2° Mobitz II & 3°: Admit all to Tele ward for cardiology consult & PPM

Pearls

• Avoid atropine for reversal of AV block as this can worsen conduction

• Have transcutaneous pacer attached & ready for use in high-risk pts

• Mobitz II is concerning b/c risk of progression to 3°



If you find an error or have any questions, please email us at admin@doctorlib.org. Thank you!